Search datasets
-
UNLOXCYT (cosibelimab) is a monoclonal antibody that blocks PD-L1 to help the immune system fight cancer cells. It's given as an intravenous injection, with each vial containing 300 mg in 5 mL....
Search relevance: 172.35 | Views last month: 0 | Catalog Last Checked: September 10, 2026 at 08:08 PM